Clinical Trials Directory

Trials / Completed

CompletedNCT06435624

Effectiveness of Intelligent Rehabilitation Robot Training System Combined With Repetitive Facilitative Exercise on Upper Limb Motor Function After Stroke: a Randomized Control Trial.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
81 (actual)
Sponsor
Nanjing Mingzhou Rehabilitation Hospital · Academic / Other
Sex
All
Age
18 Years – 74 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to learn if intelligent rehabilitation robot training system combined with repetitive facilitative exercise (RFE) work to treat stroke in adults. The main questions it aims to answer are: Does drug intelligent rehabilitation robot training system combined with RFE improve the upper limb motor function of participants? Can the combination of intelligent rehabilitation robot training system and RFE achieve better effects? Researchers will compare 3 groups (RFE, intelligent rehabilitation robot training system under RFE, and conventional therapy) to see if intelligent rehabilitation robot training system and RFE works to treat stroke. Participants will: Receive treatment for 4 weeks Receive scale and instrument testing before and after treatment

Conditions

Interventions

TypeNameDescription
DEVICEintelligent robotic-assisted trainingUsing an intelligent robotic-assisted training (IRAT) system to simulate a real work environment, providing functional oriented treatment for stroke patients and improving upper limb motor function. The instrument used is the Burt upper limb robot training system produced by Estun Medical Co., Ltd.
OTHERrepetitive facilitative exerciseRepetitive facilitative exercise (RFE) is a new technology that combines multiple sensory stimuli and achieves facilitation and reinforcement of the reconstruction of paralyzed neural pathways through repeated and extensive directional exercise.
OTHERconventional therapyBasic training, including passive joint movement and activities of daily living exercise.

Timeline

Start date
2024-06-15
Primary completion
2024-08-31
Completion
2024-08-31
First posted
2024-05-30
Last updated
2025-03-05
Results posted
2025-03-05

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06435624. Inclusion in this directory is not an endorsement.